跳到正文
openFDA 已分级药品召回执法报告·· 26 天前精选AI 评分61

FDA 执法报告 D-0076-2027:Hikma 阿比特龙醋酸酯片批号 3047 因重量均匀度不合格列为 II 类召回

FDA drug enforcement D-0076-2027: Hikma Pharmaceuticals USA INC. — Failed Tablet/Capsule Specifications: Failed tablet specifications for weight uniformity.

AI 导读

openFDA 执法报告 D-0076-2027 显示,Hikma Pharmaceuticals USA 发起的阿比特龙醋酸酯(Abirtega)USP 250 mg 片剂召回被列为 II 类,原因是重量均匀度不符合片剂标准。

推荐理由

记录列出了阿比特龙醋酸酯片重量均匀度不合格召回的类别、批号与分销范围,便于核对批次追溯信息。

正文 · 原文

FDA drug recall enforcement report — D-0076-2027

Report issued: 2026-10-28. This is the enforcement report date, not the recall initiation date.

Scope: one classified drug product recall record; event_id may group multiple products. Unclassified records without recall numbers are outside this stream. This record is not a press release or a new enforcement finding.

The openFDA dataset is updated weekly. Report status is not a live recall status and must not be used to track the recall lifecycle. Other dates below retain their named meanings.

Complete official product record (including openFDA harmonized identifiers):

{

"address_1": "1809 Wilson Rd",

"address_2": "",

"center_classification_date": "20261023",

"city": "Columbus",

"classification": "Class II",

"code_info": "Lot #: 3047, Exp Date July 2027.",

"country": "United States",

"distribution_pattern": "Nationwide within the United States",

"event_id": "100046",

"initial_firm_notification": "Letter",

"more_code_info": "",

"openfda": {

"application_number": [

"ANDA208339"

],

"brand_name": [

"ABIRTEGA"

],

"generic_name": [

"ABIRATERONE ACETATE"

],

"is_original_packager": [

true

],

"manufacturer_name": [

"CivicaScript, LLC"

],

"package_ndc": [

"82249-011-12"

],

"product_ndc": [

"82249-011"

],

"product_type": [

"HUMAN PRESCRIPTION DRUG"

],

"route": [

"ORAL"

],

"rxcui": [

"1100075",

"2702601"

],

"spl_id": [

"692d596d-5465-4611-82f7-5d50c37270a2"

],

"spl_set_id": [

"2f932015-28b2-4f44-ac04-772e982e13e9"

],

"substance_name": [

"ABIRATERONE ACETATE"

],

"unii": [

"EM5OCB9YJ6"

],

"upc": [

"0382249011123"

]

},

"postal_code": "43228-9579",

"product_description": "Abirtega (abiraterone acetate) USP, 250 mg, 120-count bottles, Rx only, Rx only, Mfd for: Hikma Pharmaceuticals USA Inc., Berkley Heights, NJ 07922 USA by: Arab Pharmaceuticals Manufacturing PSC PO Box 41, Sahab-Jordon, NDC 82249-011-12.",

"product_quantity": "2136 bottles",

"product_type": "Drugs",

"reason_for_recall": "Failed Tablet/Capsule Specifications: Failed tablet specifications for weight uniformity.",

"recall_initiation_date": "20261006",

"recall_number": "D-0076-2027",

"recalling_firm": "Hikma Pharmaceuticals USA INC.",

"report_date": "20261028",

"state": "OH",

"status": "Ongoing",

"voluntary_mandated": "Voluntary: Firm initiated"

}

来源:openFDA 已分级药品召回执法报告 · api.fda.gov